Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Abstract Text:

David Eisenman,Laura M Bogart,Chloe E Bird,Rebecca L Collins,Daniela Golinelli,Allen Fremont,Robin Beckman,William Cunningham,

We sought to examine whether diffusion of new HIV technologies differed by gender in the United States, the source of any such disparities, and whether disparities narrow over time as technologies become more established. In particular, we assess how rates of use of highly active antiretroviral therapy (HAART) varied between males and females during the late 1990s, when HAART was rapidly diffusing. We examined data from a prospective cohort study of a national probability sample of 1421 HIV-infected adults in medical care who were enrolled in the HIV Cost and Services Utilization Study (HCSUS) from January 1996 to December 1998. We found that HAART use substantially increased between 1996 and early 1998 for all groups. Women were less likely to receive HAART at all time points, although the diffusion of HAART between 1996 and 1998 reduced gender disparities. Gender disparities in 1998 were only partially explained by women's lower income and educational levels. We conclude that HAART therapy diffused more slowly to HIV-positive females than other groups. Policies that reduce the impact of income and education inequalities on health care may help to narrow gender disparities for new HIV technologies, but other factors may also disadvantage women.

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Publishing Authors By Initials

D Eisenman,LM Bogart,CE Bird,RL Collins,D Golinelli,A Fremont,R Beckman,W Cunningham,

For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

PUBMED ID PMID:

MEDLINE DATE:

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: AIDS patient care and STDs

VOLUME: 21

Page Numbers: 390-9

Journal Abbreviation:

ISSN: 1087-2914

DAY: 3

MONTH: Jun

YEAR: 2007

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9607225

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Keywords Mesh Terms:

KEYWORDS: Time Factors

MESH TERMS: economics

Chemical & Substance for Abstract: Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. Information

Substance Name: Anti-HIV Agents

Registry Number: 0

Grant and Affiliation Information for Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.

AFFILIATION: Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. David_Eisenman@rand.org

Country: United States

AGENCY: United States AHRQ

GRANT: U-01HS08578

ACRONYM: HS

MEDLINETA: AIDS Patient Care STDS

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy Related Publications

• Benztropine for the treatment of intractable hiccups: New indication for an old drug?
• Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
• Characterization of two POU transcription factor family members from the urochordate Oikopleura dioica.
• Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.
• Differential effects of water deprivation and rehydration on Fos and FosB/DeltaFosB staining in the rat brainstem.
• Ethanol self-administration and alterations in the livers of the cynomolgus monkey, Macaca fascicularis.
• FOS expression induced by an ethanol-paired conditioned stimulus.
• HIV System Navigation: an emerging model to improve HIV care access.
• Identification of central nervous system sites involved in the water diuresis response elicited by central microinjection of nociceptin/ Orphanin FQ in conscious rats via c-Fos and inducible cAMP early repressor immunocytochemistry.
• Improving health outcomes among youth with poorly controlled type I diabetes: the role of treatment fidelity in a randomized clinical trial of multisystemic therapy.
• Inhibition of serum bactericidal reaction by lipopolysaccharide.
• Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations.
• Isolation of a novel fish thymidylate kinase gene, upregulated in Atlantic salmon (Salmo salar L.) following infection with the monogenean parasite Gyrodactylus salaris.
• Neurodevelopment of infants with single-suture craniosynostosis: presurgery comparisons with case-matched controls.
• Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy.
• Role of test activity in ethanol-induced disruption of place preference expression in mice.
• Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction.
• Strategies to screen for adrenal suppression in children with asthma should take account of compliance with inhaled corticosteroids.
• Substrate specificity of RdgB protein, a deoxyribonucleoside triphosphate pyrophosphohydrolase.
• T regulatory cells: sentinels against autoimmune heart disease.
• The Evolution of HIV illness representation among marginally housed persons.
• The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
• The association between life chaos, health care use, and health status among HIV-infected persons.
• The differential diagnosis of vertical strabismus from prism cover test data using an artificially intelligent expert system.
• The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population.
• The impact of managed care on access to highly active antiretroviral therapy and on outcomes among Medicaid beneficiaries with AIDS.
• Type and pattern of illicit drug use and access to health care services for HIV-infected people.
• Typical or pathological? Routinized and compulsive-like behaviors in children and young people with Down syndrome.
• Urinary hepcidin in congenital chronic anemias.
• Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.